Tuesday, the FDA granted accelerated approval for ImmunoGen Inc’s (NASDAQ: IMGN) Elahere (mirvetuximab soravtansine-gynx) for folate receptor alpha (FRα)-positive, platinum-resistant epithelial ...
Tag: ImmunoGen
Why Are ImmunoGen Shares Trading Lower Today
Motley Fool Why Shares of Coinbase Fell Today Shares of the large crypto exchange Coinbase (NASDAQ: COIN) fell nearly 5% today after a big investor took a short position in the company, which currentl...